登陆
当前位置: 首页 >> 检索结果

结果排序

文献格式

出版时间

出版类型

出版语言
共有 7412 条符合本次的查询结果， 用时 5.9041344 秒

6361. Trends in population health and demography.

作者: Nico Keilman.
来源: Lancet. 2021年398卷10300期581页

6362. Trends in population health and demography.

作者: Stuart Gietel-Basten.;Tomas Sobotka.
来源: Lancet. 2021年398卷10300期580-581页

6363. Trends in population health and demography.

作者: Jane N O'Sullivan.
来源: Lancet. 2021年398卷10300期580页

6364. Trends in population health and demography.

作者: Nanna Maaløe.;Natasha Housseine.;Tarek Meguid.;Siri Tellier.;Jos van Roosmalen.;Dan W Meyrowitsch.;Thomas van den Akker.
来源: Lancet. 2021年398卷10300期579-580页

6365. Voriconazole pharmacogenetics.

作者: Nicolas Pallet.;Marie Anne Loriot.
来源: Lancet. 2021年398卷10300期578页

6366. Voriconazole pharmacogenetics - Authors' reply.

作者: Johan A Maertens.;Hetty A Waskin.;Rachel Marceau West.;Peter M Shaw.
来源: Lancet. 2021年398卷10300期578-579页

6367. Min Mehta: surgeon who helped children with scoliosis.

作者: Georgina Ferry.
来源: Lancet. 2021年398卷10300期572页

6368. Chiquita Brooks-LaSure: innovative US federal health director.

作者: Susan Jaffe.
来源: Lancet. 2021年398卷10300期571页

6369. Focusing on island health.

作者: Jacqui Thornton.
来源: Lancet. 2021年398卷10300期569-570页

6370. Lebanese health care racked by medicine shortages.

作者: Saleyha Ahsan.
来源: Lancet. 2021年398卷10300期568页

6371. Haiti's health woes intensify.

作者: Joe Parkin Daniels.
来源: Lancet. 2021年398卷10300期567页

6372. The NHS: the many challenges for leadership.

作者: The Lancet.
来源: Lancet. 2021年398卷10300期559页

6373. A Lebanese physician's dilemma: not how, but with what?

作者: Abdul Rahman Bizri.;Pierre Bou Khalil.
来源: Lancet. 2021年398卷10303期841页

6374. Does vaccine ageism amount to gerontocide?

作者: Peter Lloyd-Sherlock.;Gideon Lasco.;Martin McKee.;Arokiasamy Perianayagam.;Lucas Sempé.
来源: Lancet. 2021年398卷10304期952-953页

6375. Pharmaceutical companies should pay for raiding nature's medicine cabinet.

作者: Adam D Canning.;Russell G Death.;Nathan J Waltham.
来源: Lancet. 2021年398卷10303期840-841页

6376. SARS-CoV-2 vaccination in pregnancy: a unique opportunity for equity.

作者: Erkan Kalafat.;Laura A Magee.;Peter von Dadelszen.;Pat O'Brien.;Asma Khalil.
来源: Lancet. 2021年398卷10304期951页

6377. The costs of PEPFAR's leadership vacuum.

作者: José M Zuniga.;Asia Russell.;Richard Lusimbo.;Sibongile Tshabalala.
来源: Lancet. 2021年398卷10302期741页

6378. Serial intervals in SARS-CoV-2 B.1.617.2 variant cases.

作者: Rachael Pung.;Tze Minn Mak.; .;Adam J Kucharski.;Vernon J Lee.
来源: Lancet. 2021年398卷10303期837-838页

6379. The use of inhaled corticosteroids in early-stage COVID-19.

作者: Dee Mangin.;Michelle Howard.
来源: Lancet. 2021年398卷10303期818-819页

6380. Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study.

作者: Saad Z Usmani.;Alfred L Garfall.;Niels W C J van de Donk.;Hareth Nahi.;Jesus F San-Miguel.;Albert Oriol.;Laura Rosinol.;Ajai Chari.;Manisha Bhutani.;Lionel Karlin.;Lotfi Benboubker.;Lixia Pei.;Raluca Verona.;Suzette Girgis.;Tara Stephenson.;Yusri Elsayed.;Jeffrey Infante.;Jenna D Goldberg.;Arnob Banerjee.;María-Victoria Mateos.;Amrita Krishnan.
来源: Lancet. 2021年398卷10301期665-674页
There is a need for novel therapies for relapsed or refractory multiple myeloma, and B-cell maturation antigen (BCMA) is a validated target. Teclistamab is a bispecific antibody that binds BCMA and CD3 to redirect T cells to multiple myeloma cells. The aim of the MajesTEC-1 study was to evaluate the safety, tolerability, and preliminary efficacy of teclistamab in patients with relapsed or refractory multiple myeloma.
共有 7412 条符合本次的查询结果， 用时 5.9041344 秒